Matthew W. Towse, SVP and Chief Financial Office at NxStage Medical, Inc. (NXTM), sold 4,300 shares at $24.16 ($104K) on 2017-07-20, disclosed to the SEC on 2017-07-21.
Seasonal sale ($104k) by SVP and Chief Financial Office — this insider has traded NXTM in July in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NXTM | SELL | 2017-08-23 | $126K | — | Filing → |
| NXTM | SELL | 2017-06-21 | $100K | — | Filing → |
| NXTM | SELL | 2017-05-23 | $92K | — | Filing → |